Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Journal of Intensive Care Medicine|March 14, 2019
The Performance of Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis in Critically Ill PatientsNikhil K Meena, Odai Sinokrot, Abhijit Duggal, et al.Journal of Clinical Pathology|September 11, 2023
Myeloid madness: assessing diagnostic inconsistency between the new WHO and ICC schemes for myelodysplastic/myeloproliferative neoplasmsLeah G Benton, Michael Edward Kallen, Jonathan L Jacobs, et al.The American Journal of Surgical Pathology|March 10, 2026
Comprehensive Assessment of CD19 Immunohistochemical Staining in Classic Hodgkin LymphomaSarah R Helman, Fikru Merechi, Hanan Alharthy, et al.JAMA Network Open|January 16, 2019
Human Papillomavirus T-Cell Cross-reactivity in Cervical Cancer: Implications for Immunotherapy Clinical Trial DesignSarah R Helman, Sanja Stevanovic, Tracy E Campbell, et al.Journal of Hematopathology|October 9, 2018
High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based RegimenZeba N Singh, Vu H Duong, Rima Koka, et al.Leukemia Research Reports|November 10, 2022
Therapy-related B-lymphoblastic leukemia after multiple myelomaMichael E Kallen, Rima Koka, Zeba N Singh, et al.Annals of Hematology|July 18, 2020
Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective studyVu H Duong, Kebede H Begna, Sarah Kashanian, et al.Clinical Case Reports|April 4, 2015
Fulminant onset of acute leukemia from normal hematopoiesis within 3 months of follow up for multiple myeloma treated with total therapy protocolsZeba N Singh, Yogesh Jethava, Ginell R Post, et al.Plos Pathogens|October 28, 2015
Systematic Identification of Cyclic-di-GMP Binding Proteins in Vibrio cholerae Reveals a Novel Class of Cyclic-di-GMP-Binding ATPases Associated with Type II Secretion SystemsKevin G Roelofs, Christopher J Jones, Sarah R Helman, et al.Journal for Immunotherapy of Cancer|August 29, 2019
Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1Bridget Marcinkowski, Sanja Stevanović, Sarah R Helman, et al.Pageof 3